Han Chaoran, Xue Hongyu, Yang Shengtao, Gao Binghong
School of Athletic Performance, Shanghai University of Sport, Shanghai 200438, China.
School of Physical Education, Shanghai University of Sport, Shanghai 200438, China.
Diabetes Res Clin Pract. 2025 Apr;222:112077. doi: 10.1016/j.diabres.2025.112077. Epub 2025 Mar 8.
This meta-analysis investigated the impact of resistance exercise training (RET) on metabolic syndrome (MetS) markers in patients with type 2 diabetes mellitus (T2DM) by synthesizing evidence from randomized controlled trials (RCTs). A systematic search was conducted in four databases up to September 2024. Data were analyzed using random-effects models to calculate mean differences (MD) and 95 % confidence intervals (CI). Fifty RCTs involving 2271 participants (1186 in the intervention group, 1085 in the control group) were included. RET significantly improved key MetS markers, including reductions in fasting blood glucose (MD = -7.09 mg/dl; p < 0.00001), triglyceride (MD = -14.05 mg/dl; p < 0.0001), systolic (MD: -4.13 mmHg; p = 0.0004) and diastolic (MD: -2.03 mmHg; p = 0.02) blood pressure, and waist circumference (MD = -2.18 cm; p < 0.00001). Additionally, RET was associated with increased high-density lipoprotein levels (MD: 1.86 mg/dl; p = 0.002). Subgroup analyses indicated consistent benefits across varing intervention durations and participant genders, underscoring the broad applicability of RET for diverse T2DM populations. These findings suggest that RET is an effective intervention for improving MetS markers in individuals with T2DM. However, limitations such as high heterogeneity and small sample sizes may affect generalizability.
本荟萃分析通过综合随机对照试验(RCT)的证据,研究了抗阻运动训练(RET)对2型糖尿病(T2DM)患者代谢综合征(MetS)标志物的影响。截至2024年9月,在四个数据库中进行了系统检索。使用随机效应模型分析数据,以计算平均差(MD)和95%置信区间(CI)。纳入了50项RCT,涉及2271名参与者(干预组1186名,对照组1085名)。RET显著改善了关键的MetS标志物,包括空腹血糖降低(MD = -7.09 mg/dl;p < 0.00001)、甘油三酯降低(MD = -14.05 mg/dl;p < 0.0001)、收缩压(MD:-4.13 mmHg;p = 0.0004)和舒张压(MD:-2.03 mmHg;p = 0.02)降低,以及腰围减小(MD = -2.18 cm;p < 0.00001)。此外,RET与高密度脂蛋白水平升高有关(MD:1.86 mg/dl;p = 0.002)。亚组分析表明,在不同的干预持续时间和参与者性别中均有一致的益处,强调了RET对不同T2DM人群的广泛适用性。这些发现表明,RET是改善T2DM个体MetS标志物的有效干预措施。然而,诸如高异质性和小样本量等局限性可能会影响结果的普遍性。